Back to
FRONTIER CAPITAL MANAGEMENT CO LLC
SGEN
Showing 0 of 8 quarters
Position history for
FRONTIER CAPITAL MANAGEMENT CO LLC's holdings in SEATTLE GENETICS INC
As of its Q3 2020 13F, Frontier Capital Management held 466,983 shares of SGEN (Seattle Genetics), worth $91.4M. Frontier Capital Management's 13F filings listed SGEN from Q1 2019 to Q3 2020, 7 quarterly filings. SGEN was 0.8% of Frontier Capital Management's reported 13F portfolio.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.